Abstract:Ji Zhu, 1, &ast Hang Chen, 2, &ast Jianan Guo, 2 Chen Zha, 1 Dezhao Lu 2 1 The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province), Hangzhou, People's Republic of China; 2 School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dezhao Lu, Email Introduction: Atherosclerosis (AS) is the underlying cause of cardiovascular events. Endothelial cell mitochondrial damage and pyroptosis are important factors contributing to AS. Changes in internal mitochondrial conformation and increase in reactive oxygen species (ROS) lead to the disruption of mitochondrial energy metabolism, activation of the NLRP3 inflammasome and pyroptosis, which in turn affect atherogenesis by impairing endothelial function. AMPK is a core player in the regulation of cellular metabolism, not only by regulating mitochondrial homeostasis but also by regulating cellular inflammatory responses. Sodium tanshinone IIA sulfonate (STS), a water-soluble derivative of tanshinone IIA, has significant antioxidant and anti-inflammatory effects, and roles in cardiovascular protection. Purpose: In this study, we investigated whether STS plays a protective role in AS by regulating endothelial cell mitochondrial function and pyroptosis through an AMPK-dependent mitochondrial pathway. Methods and Results: Male ApoE −/− mice and HUVECs were used for the experiments. We found that STS treatment largely abrogated the upregulation of key proteins in aortic vessel wall plaques and typical pyroptosis signaling in ApoE −/− mice fed a western diet, consequently enhancing pAMPK expression, plaque stabilization, and anti-inflammatory responses. Consistently, STS pretreatment inhibited cholesterol crystallization (CC) -induced cell pyroptosis and activated pAMPK expression. In vitro, using HUVECs, we further found that STS treatment ameliorated mitochondrial ROS caused by CC, as evidenced by the finding that STS inhibited mitochondrial damage caused by CC. The improvement of endothelial cell mitochondrial function by STS is blocked by dorsomorphin (AMPK inhibitor). Consistently, the blockade of endothelial cell pyroptosis by STS is disrupted by dorsomorphin. Conclusion: Our results suggest that STS enhances maintenance of mitochondrial homeostasis and inhibits mitochondrial ROS overproduction via AMPK, thereby improving endothelial cell pyroptosis during AS. Keywords: atherosclerosis, pyroptosis, tanshinone IIA, AMPK, mitochondria Atherosclerosis (AS) is a commonly recognized metabolic and chronic inflammatory disease. And AS is accompanied by endothelial dysfunction, lipid deposition, and vascular wall thickening. 1 AS is a significant cardiovascular burden and a leading cause of death worldwide, and is recognized as the basis of cardiovascular disease (CVD). 2,3 ASCVD results in approximately 2.4 million deaths annually in China. 4–6 Vascular endothelial cells constitute the inner wall of arterial vessels, and the morphological integrity and balance of their function significantly contribute to vascular health. 7 Endothelial dysfunction, structural alterations, and chronic inflammation of the vascular wall are known to be critical steps in AS development, as well as in the instability of advanced plaques. 8,9 However, the underlying mechanisms and appropriate means to clinically manage the disease require further investigation. Endothelial cell dysfunction is characterized by proinflammatory cytokines, elevated ROS, disrupted vascular tone, and various types of programmed cell death (PCD), including apoptosis, autophagy, pyroptosis, and necroptosis. 10 Pyroptosis is a newly discovered form of programmed inflammatory cell death, which is suggested to contribute to vascular endothelial cell dysfunction and the pathogenesis of AS. 11,12 Pyroptosis can be driven by the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, which is composed of NLRP3, the adaptor apoptosis-associated speck-like protein containing a CARD (ASC), and pro-caspase1. 13,14 Once activated, NLRP3 recruits and cleaves pro-caspase1 into its active forms, which process pro-inflammatory cytokines such as IL-1β and IL-18 and HMGB1. 15 Active forms of caspase-1 also cleave gasdermin D (GSDMD), separating the N-terminal pore-forming structural domain (PFD) of GSDMD from the C-terminal deterrent structural domain (RD) and the subsequent oligomerization of PFD transferred into the cell membrane. And the oligomer of GSDMD le -Abstract Truncated-

Procaspase-1 Patrolled to the Nucleus of Proatherogenic Lipid LPC-activated Human Aortic Endothelial Cells Induces ROS Promoter CYP1B1 and Strong Inflammation

Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair.

Abstract 11678: Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation

Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation

Early Hyperlipidemia Promotes Endothelial Activation Via a Caspase-1-sirtuin 1 Pathway.

Abstract 642: Caspase-4/11 Promotes A High-fat Diet And Chronic Kidney Disease-accelerated Vascular Inflammation Via Novel Caspase-4/11-il-1b Two-step Trained Immunity

Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells.

Increased Acetylation of H3K14 in the Genomic Regions That Encode Trained Immunity Enzymes in Lysophosphatidylcholine-Activated Human Aortic Endothelial Cells – Novel Qualification Markers for Chronic Disease Risk Factors and Conditional DAMPs

Abstract 19596: Endothelial Acyl-CoA Synthetase 1 is not Required for Saturated Fatty Acid- Mediated Inflammatory and Apoptotic Effects

Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.

Extracellular NLRP3 inflammasome particles are internalized by human coronary artery smooth muscle cells and induce pro-atherogenic effects

High expression of CASP1 induces atherosclerosis

Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis

Abstract 4132409: Caspase-4/11 Promotes a High-Fat Diet and Chronic Kidney Disease-Accelerated Vascular Inflammation Via Caspase-4/11-il-1b Two-Tier Trained Immunity

High Mobility Group B-1 (HMGB-1) Promotes Apoptosis of Macrophage-Derived Foam Cells by Inducing Endoplasmic Reticulum Stress

Beclin1 controls caspase-4 inflammsome activation and pyroptosis in mouse myocardial reperfusion-induced microvascular injury

Caspase-4/11 promotes hyperlipidemia and chronic kidney disease-accelerated vascular inflammation by enhancing trained immunity

C/Ebp Beta Acts Upstream Of Nf-Kappa B P65 Subunit In Ox-Ldl-Induced Il-1 Beta Production By Macrophages

Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis

Endothelial NLRP3 Inflammasome Activation and Arterial Neointima Formation Associated with Acid Sphingomyelinase During Hypercholesterolemia.

Role of Caspases in Ox-LDL–Induced Apoptotic Cascade in Human Coronary Artery Endothelial Cells